Tag: Antibiotics
FDA Approves New Antibiotic for Three Indications
Zevtera approved for S. aureus bloodstream infections, acute bacterial skin/skin structure infections, and bacterial pneumonia
Many Children With Sickle Cell Anemia Do Not Meet Quality Indicators
Rates of receipt of recommended antibiotic prophylaxis and annual transcranial Doppler low
Physicians ID Barriers to ‘No Antibiotic’ Strategy for Pediatric Viral Pneumonia
Challenges for clinicians include acceptance of risks of unnecessary treatment of many children to avoid adverse outcomes for some
Amid Shortage of Bicillin, FDA to Import Another Syphilis Drug
Paris-based Laboratoires Delbert is working with the FDA to temporarily import 3.5 million units of Extencilline
Five-Day Antibiotic Course Noninferior for Pediatric Febrile UTI
Five-day amoxicillin-clavulanate course noninferior to 10-day course for recurrence of UTI within 30 days
Doxycycline Postexposure Prophylaxis Does Not Avert STIs in Women
Incidence of STIs not significantly lower with doxycycline PEP than with standard care among women receiving HIV PrEP
Doxycycline Tied to Lower Risk for C. Difficile in Pneumonia Patients
Incidence of C. difficile infection reduced by 45 percent with doxycycline among patients with prior history of CDI
New Antibiotic Tackles Drug-Resistant Gonorrhea in Trial
Zoliflodacin was seen to cure uncomplicated gonorrhea infection as effectively as the current go-to treatment
IDSA: Piperacillin-Tazobactam, Cefepime Comparable for Suspected Infection
Incidence of acute kidney injury or death did not differ among those receiving cefepime and piperacillin-tazobactam
Adding Vancomycin to Cefazolin Prophylaxis Does Not Prevent Surgical Site Infections
Addition of vancomycin not superior to placebo for preventing surgical site infections in arthroplasty
